Searched for
VOLUNTARY LICENCING AGREEMENT
Stocks in news: Hero MotoCorp, Canara Bank, Bharti Airtel, Indian Hotels, SBIIndian markets opened positively, with analysts suggesting a stock-specific strategy amidst consolidation. Hero MotoCorp sees a revival in ...- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- Spectrum allocated to telcos not asset, can't be subjected to insolvency process: Supreme CourtThe decision will have ramifications in the telecommunication sector where telecom firms such as Aircel Group of Companies have invoked mor...
- India-UK FTA does not dilute New Delhi's right to issue compulsory licences: OfficialAn official clarified that the India-UK free trade agreement doesn't weaken India's power to issue compulsory licenses or add new requireme...
- India-UK trade pact subtly curtails India's ability to issue compulsory licenses: GTRIIndia's free trade agreement with the UK includes clauses on intellectual property. These clauses may limit India's ability to issue compul...
- Aurobindo to produce, supply long acting HIV treatment drugAurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through a voluntary l...
- Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...
- Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravirNatco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. "We have submitted p...
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...
- Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drugEli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...
- Government exploring possibility of Covaxin production outside IndiaThe government also intends to take up the matter with the World Health Organisation (WHO) to step up Covaxin production.
- Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN LabsThe company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...
- Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in IndiaAs the threat of compulsory licence (CL) looms over big pharma in India, companies are rushing in to sign voluntary licensing agreements th...
- MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...
- Large pharma companies back appeal for TRIPS waiver for Covid-19 cure“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time fo...
- Urban cooperative Bank promoter will have to set up a public Ltd Company before transitioning into small finance banks: RBIRBI has said that the promoters will have to incorporate a public limited company under the Companies Act, 2013 having the word ‘bank’ in i...
- Natco Pharma launches hepatitis C drug in NepalThe drug launched under the brand name Hepcinat is priced at Rs 19,900, or roughly $300 for 28 tablets, Natco said in its communication to ...
- Natco Pharma ties up with Gilead Sciences for Hepatitis C drugNatco was the only Indian generic drug maker that had filed a pre-grant patent opposition for the drug with the patent office.
- Hepatitis C drug in India to cost 49 lakh less than in USThe voluntary licencing deal promises to make the drug cheap in India as well as up to 91 countries where the Indian firms are allowed to s...
- Natco Pharma files India's first compulsory licence pleaNatco Pharma has applied for the country's first compulsory licence to sell a generic version of Bayer's patented medicine.
Load More
